Alhemo
Active substance: concizumab
INJECTION, SOLUTION · CONCIZUMAB 100 mg/mL
United StatesActive
Marketing holder: Novo Nordisk
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CONCIZUMAB · 100 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-4093-752d-9238-f64c8e761962,01a12095-c615-7190-a52b-946a339966bd,01a12098-6f20-79b2-9baf-285380e8fc5b;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0169-2080
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0169-2080 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0169-2080 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0169-2080 · Verified 2026-10-09 · open in source